BRIDGEWAY CAPITAL MANAGEMENT, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 112 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,734,901
-43.5%
633,079
-13.8%
0.07%
-43.1%
Q2 2023$4,837,554
+3.5%
734,075
+6.6%
0.12%
-6.5%
Q1 2023$4,673,808
+94.2%
688,337
+111.4%
0.12%
+100.0%
Q4 2022$2,406,184
-4.3%
325,600
+103.1%
0.06%
+31.9%
Q4 2021$2,515,000
+2.9%
160,300
+12.4%
0.05%0.0%
Q3 2021$2,444,000
-20.3%
142,6000.0%0.05%
-14.5%
Q2 2021$3,067,000
+427.0%
142,600
+307.4%
0.06%
+511.1%
Q3 2016$582,000
+48.5%
35,0000.0%0.01%
+50.0%
Q2 2016$392,000
+33.8%
35,0000.0%0.01%
+20.0%
Q1 2016$293,000
-46.9%
35,000
-41.0%
0.01%
-50.0%
Q4 2015$552,000
-17.5%
59,3000.0%0.01%
-28.6%
Q3 2015$669,000
-11.2%
59,3000.0%0.01%
-6.7%
Q2 2015$753,000
+2.2%
59,300
-25.2%
0.02%0.0%
Q1 2015$737,000
-35.7%
79,300
-0.9%
0.02%
-42.3%
Q4 2014$1,146,000
+38.1%
80,0000.0%0.03%
+23.8%
Q3 2014$830,000
-35.9%
80,0000.0%0.02%
-38.2%
Q2 2014$1,294,000
-62.9%
80,000
-62.8%
0.03%
-66.0%
Q1 2014$3,490,000
+13.3%
214,792
-13.4%
0.10%
+6.4%
Q4 2013$3,079,000
+13.3%
248,1000.0%0.09%
+1.1%
Q3 2013$2,717,000
+35.0%
248,100
-0.4%
0.09%
+16.2%
Q2 2013$2,013,000249,1000.08%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders